Page 14 - MedTech 1920_29Oct
P. 14

body to prevent the formation of pressure ulcers.
Fostering collaboration
Increasingly, innovation in MedTech will require greater collaboration among key stakeholders - companies, universities as well as governments. This feeds into Singapore’s strengths.
Speaking at the launch of Lucence Diagnostics’ new headquarters and laboratory, Senior Minister of State for Trade and Industry Dr Koh Poh Koon said, “One of the key strengths of Singapore’s R&D ecosystem lie in the strong partnerships between our companies and the public sector. Global and local start-ups, multinational corporations and local enterprises have been working closely with key public sector organisations, such as A*STAR, Institutes of Higher Learning (IHLs), Ministry of Health (MoH), hospitals and the regulators to strengthen the growth and competitiveness of the MedTech industry.”
The collaboration between GE Healthcare and A*STAR is a  ne example. As part of the collaboration, the two partners are developing digital solutions, including a diagnostic imaging system for Parkinson’s Disease and advanced capabilities for surgery motion tracking. GE Healthcare brings to the table its expertise in medical and IT while A*Star
provides pro ciency in data analytics and high-performance computing.
Working together, GE Healthcare and A*Star have also used high- performance computing to improve the Positron Emission Tomography (PET) scan procedure, which translates into faster scans and shorter waiting times for patients, shaving about 15 minutes off the work ow, which would typically take almost 40 minutes to complete.
In July 2019, a new national Health Technologies Consortium (HealthTEC) was set up to enhance collaboration within the eco-system and foster innovation. Housed
at the National University of Singapore’s Institute of Health Innovation & Technology (iHealthtech), the consortium brings together industry partners with academics at research institutes and IHLs to accelerate the process of turning medical discoveries into novel health technology.
HealthTEC encourages industry- academia interactions through regular networking sessions, workshops, roundtable discussions and scienti c symposia and acts as a national resource in R&D and commercialisation by providing seed grants and facilitating licensing of locally developed technologies.

   12   13   14   15   16